MIP-DILI
University of Freiburg , Universitäts-Augenklinik Bonn , Leiden University , SOLVO BIOTECHNOLOGY , Interface Europe (Belgium) , Orion Corporation (Finland) , GERMAN CANCER RESEARCH CENTER , Utrecht University , KI , VU , SARD , MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN , BMS , AstraZeneca (Sweden) , LL , H. LUNDBECK A/S , Takara Bio Europe AB , KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN , University of Liverpool , UR1 , ...
Start a new DMP in Loading
University of Freiburg , Universitäts-Augenklinik Bonn , Leiden University , SOLVO BIOTECHNOLOGY , Interface Europe (Belgium) , Orion Corporation (Finland) , GERMAN CANCER RESEARCH CENTER , Utrecht University , KI , VU , SARD , MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN , BMS , AstraZeneca (Sweden) , LL , H. LUNDBECK A/S , Takara Bio Europe AB , KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN , University of Liverpool , UR1 , AbbVie , CXR BIOSCIENCES LIMITED , KLC , UCB , GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. , Johnson & Johnson (United States) , Janssen (Belgium) , Eli Lilly and Company Limited , IRIS
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=corda_______::11971d2a464dff06db0db6c070612907&type=result"></script>');
-->
</script> For further information contact us at helpdesk@openaire.eu